The USPSTF Recommendation Statement on Coronary Heart Disease Risk Assessment

Abstract

Letters16 March 2010The USPSTF Recommendation Statement on Coronary Heart Disease Risk AssessmentRobert J. Glynn, PhD, ScDRobert J. Glynn, PhD, ScDFrom Brigham & Women's Hospital, Harvard Medical School, Boston, MA 02115.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-152-6-201003160-00015 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail TO THE EDITOR:The statement from the U.S. Preventive Services Task Force (USPSTF) (1) that “persons with low (<10%) Framingham risk scores do not benefit from aggressive risk factor modification” and the conclusion that high-sensitivity C-reactive protein (CRP) does not improve a physician's ability to guide treatment do not reflect current randomized trial data. The USPSTF conclusions should be of particular concern for women, almost all of whom have Framingham risk scores less than 10%.JUPITER (Justification for the Use of Statins in Primary Prevention: An Intervention Trial Evaluating Rosuvastatin) (2) studied apparently healthy men and women with high-sensitivity CRP ...